Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization

PHASE4CompletedINTERVENTIONAL
Enrollment

1,012

Participants

Timeline

Start Date

April 30, 2003

Conditions
Coronary Heart Disease
Interventions
DEVICE

Sirolimus-eluting stent

DEVICE

Paclitaxel-eluting stent

Trial Locations (1)

3010

University Hospital Bern, Bern

All Listed Sponsors
collaborator

University of Zurich

OTHER

lead

University of Bern

OTHER

NCT00297661 - Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization | Biotech Hunter | Biotech Hunter